Expertise in
9
conditions

Dr. Marcelo Kugelmas

Gastroenterology
10103 Ridgegate Pkwy, Ste 312, 
Lone Tree, CO 
Accepting New Patients
Offers Telehealth
32 Years of Experience
Expertise in
9
conditions
10103 Ridgegate Pkwy, Ste 312, 
Lone Tree, CO 

Overview

Marcelo Kugelmas is a Gastroenterologist in Lone Tree, Colorado. Dr. Kugelmas has been practicing medicine for over 32 years is highly rated in 9 conditions, according to our data. His top areas of expertise are Cirrhosis, Visceromegaly, Non-Alcoholic Fatty Liver Disease, Endoscopy, and Colonoscopy. Dr. Kugelmas is currently accepting new patients.

His clinical research consists of co-authoring 24 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

University Of Buenos Aires

Residency

LAC/USC Medical Center

Specialties

Gastroenterology

Licenses

Internal Medicine in CO

Fellowships

Cleveland Clinic Foundation
University of Kentucky College of Medicine

Hospital Affiliations

Hca-Healthone Dba Swedish Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Denver Health Medical Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

South Denver Gastroenterology, PC
10103 Ridgegate Pkwy, Ste 312, Lone Tree, CO 80124

Additional Areas of Focus

Dr. Kugelmas has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Enrollment Status: Completed
Publish Date: September 16, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (PBC) With or Without an Inadequate Response to Ursodeoxycholic Acid (UDCA)
A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (PBC) With or Without an Inadequate Response to Ursodeoxycholic Acid (UDCA)
Enrollment Status: Completed
Publish Date: May 18, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Terminated
Publish Date: November 25, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

24 Total Publications

Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial.
Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial.
Journal: Journal of hepatology
Published: March 21, 2025
Similar Doctors
Expertise in
50
conditions
Dr. Douglas Adler
Gastroenterology
Expertise in
50
conditions
Dr. Douglas Adler
Gastroenterology

Peak Gastroenterology Associates - Lonetree

9101 Kimmer Dr Ste 1100, 
Lone Tree, CO 
 (9.6 miles away)
303-424-2535
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Douglas Adler is a Gastroenterologist in Lone Tree, Colorado. Dr. Adler is highly rated in 50 conditions, according to our data. His top areas of expertise are Hereditary Pancreatitis, Cholecystitis, Acute Pancreatitis, Endoscopy, and Colonoscopy. Dr. Adler is currently accepting new patients.

Expertise in
33
conditions
Dr. Sachin Wani
Gastroenterology
Expertise in
33
conditions
Dr. Sachin Wani
Gastroenterology

University Of Colorado Hospital

1665 Aurora Ct Fl 2, 
Aurora, CO 
 (10.0 miles away)
720-848-0000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sachin Wani is a Gastroenterologist in Aurora, Colorado. Dr. Wani is highly rated in 33 conditions, according to our data. His top areas of expertise are Barrett Esophagus, Colorectal Polyps, Gastroesophageal Reflux Disease (GERD), Endoscopy, and Colonoscopy.

Expertise in
27
conditions
Dr. Robert Harmon
Gastroenterology
Expertise in
27
conditions
Dr. Robert Harmon
Gastroenterology

Peak Gastroenterology Associates - Lonetree

9101 Kimmer Dr Ste 1100, 
Lone Tree, CO 
 (9.6 miles away)
303-424-2535
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Harmon is a Gastroenterologist in Lone Tree, Colorado. Dr. Harmon is highly rated in 27 conditions, according to our data. His top areas of expertise are Choledocholithiasis, Bile Duct Obstruction, Gallstones, Gastrectomy, and Endoscopy. Dr. Harmon is currently accepting new patients.

Frequently Asked Questions about Dr. Marcelo Kugelmas

How do I make an appointment with Dr. Marcelo Kugelmas?

You can book an appointment with Dr. Marcelo Kugelmas by calling their office at 303-788-8888. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Marcelo Kugelmas a top-rated expert for Cirrhosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Marcelo Kugelmas is classified as an Distinguished expert for Cirrhosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Marcelo Kugelmas specialize in?

While Dr. Marcelo Kugelmas is a Gastroenterology, they have specific expertise in Cirrhosis, Visceromegaly, and Non-Alcoholic Fatty Liver Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Marcelo Kugelmas participate in research or clinical trials?

Yes. Dr. Marcelo Kugelmas has published 24 articles and abstracts on conditions like Cirrhosis. You can view a list of Dr. Marcelo Kugelmas's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Marcelo Kugelmas accept my insurance?

Dr. Marcelo Kugelmas accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 303-788-8888 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kugelmas's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 19 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile